| 29 Oct Morning | 30 Oct Morning | 31 Oct Morning |
|
Session 5. Pharmacogenetics, Omics, and Informatics |
Session 4. Personalized Therapy in Clinical Medicine |
Session 5. Pharmacogenetics, Omics, and Informatics |
| 29 Oct Afternoon | 30 Oct Afternoon | 31 Oct Afternoon |
|
Session 1. Mechanisms of Diseases Session 2. Personalized Preventive Medicine |
Session 3. Diagnostics in Personalized Medicine |
Session 6. Precision Oncology |
Session 5. Pharmacogenetics, Omics, and Informatics
Date: 29 October 2025 (Wednesday)
Time: 9:00 (CET) | 04:00 (EDT) | 16:00 (CST)
|
CET |
Speaker |
Title |
|
09:00-09:10 |
Prof. Dr. Kenneth Pritzker |
Opening Speech |
|
09:10-09:20 |
Prof. Stefania Nobili |
Welcome from the Session Chair |
|
09:20-09:35 |
Hala M. Alzeer |
Artificial Intelligence in Melanoma: Integrating Multi-Omics Data for Precision Oncology and Personalized Gene Therapy |
|
09:35-09:50 |
Vy Ong |
Precision Proteomics for Personalized Medicine: A Unified MS1/MS2 Linear Mixed-Effects Model for Robust Biomarker Identification |
|
09:50- 10:05 |
Sakshi Mishra |
Machine Learning – Driven Identification of Multi-Target Repurposable Drugs for Colorectal Cancer Using Transcriptomics and Network Pharmacology |
|
10:05-10:20 |
Ana Carolina Maldonado da Costa e Silva |
Bioinformatics screening of phenylpropanoids from Pyrostegia venusta for treatment of ER+ Breast Cance |
|
10:20-10:35 |
Yao Wei |
Structural Insights into CYP3A4–P-gp Interactions and Their Role in Personalized Autoimmune Drug Therapy |
|
10:35-10:50 |
Makrina Katsanopoulou |
Anti-Inflammatory and Antiplatelet Effects of NSAIDs and Clopidogrel on PAF and ADP Pathways: In Vitro Assessment Using Human Platelets |
|
10:50-11:05 |
Bijak Rabbani |
Advanced Cardiovascular Risk Stratification through Combined Clinical, Polygenic, and Monogenic Risk Models |
|
11:05-14:00 |
BREAK |
Session 1. Mechanisms of Diseases
Date: 29 October 2025 (Wednesday)
Time: 14:00 (CET) | 09:00 (EDT) | 21:00 (CST)
|
CET |
Speaker |
Title |
|
14:00–14:10 |
Dr. Seungil Ro |
Welcome from the session chair |
|
14:10–14:35 |
Dr. Christopher Farrell |
Drug resistance in chemotherapy-naive colorectal patients |
|
14:35-15:00 |
Dr. Seeun Ha |
Post-surgical adhesions impair colonic transit through cellular remodeling |
|
15:00-15:35 |
Dr. Davide Barbagallo |
Identification of a new feedforward ceRNA network involving the kinase PIM1 and the circRNA circPIM1, predicted to be responsible for the relapse of WHO grade 2 meningioma |
|
15:35-16:00 |
Dr. Rajan Singh |
Decoding Gastroparesis: A Paradigm Shift to Precision Pathophysiology & Therapy |
|
16:00-16:15 |
Kevin Liu |
Investigating the Role of CD151 in Systemic Breast Cancer Metastasis |
|
16:15-16:30 |
Jhon Esterilla-Viafara |
The pivotal role of structurally divergent but functionally convergent genes in Wilson’s Disease: A bioinformatics approach |
|
16:30-17:00 |
BREAK |
|
Session 2. Personalized Preventive Medicine
Date: 29 October 2025 (Wednesday)
Time: 17:00 (CET) | 12:00 (EDT) | 30 Oct 0:00 (CST)
|
CET |
Speaker |
Title |
|
17:00–17:10 |
Dr. Raghu Sinha |
Opening Speech |
|
17:10-17:35 |
Dr. Raghu Sinha |
The Whole Human |
|
17:35-17:50 |
Stefan Thottunkal |
Comparing LLM Output to Physician Notes for Pharmacogenomics |
|
17:50-18:05 |
Alisa Pautova |
Modulation of microbiota metabolism for the prevention of postoperative complications in patients undergoing cardiac surgery: results of a pilot randomized controlled trial |
|
18:05-18:20 |
Swati Rai |
Integrating Multi-Omics and Machine Learning for Subtype-Specific Risk Stratification in Breast Cancer: A Step Toward Personalized Preventive Medicine |
Session 4. Personalized Therapy in Clinical Medicine
Date: 30 October 2025 (Thursday)
Time: 9:00 (CET) | 04:00 (EDT) | 16:00 (CST)
|
CET |
Speaker |
Title |
|
09:00–09:10 |
Dr. Taulant Muka |
Welcome from the session chair |
|
09:10-09:45 |
Dr. Taulant Muka |
From Personalized Medicine to Personalized Learning: Rethinking Continuing Education |
|
09:45-10:10 |
Dr. Joshua Li |
Personalized Biomarkers for Diagnosis and Theragnosis of Malignant Serous Effusions |
|
10:10-10:35 |
Dr. Giacomo Fari |
Sport for People with Disability: A Rehabilitative Approach for Precision Medicine |
|
10:35-11:00 |
Dr. Kai-Uwe Lewandrowski |
Minimally Invasive Spinal Surgery Through the Lens of Personalized Care Models - A Solution To The Musculoskeletal Healthcare Crisis |
|
11:00-11:15 |
Yazun Jarrar |
Genome-Wide Screening of Pharmacogenomic Biomarkers in Jordanian Patients with Genetic Disorders |
|
11:15-11:30 |
Qin Xie |
Specialized Interventional Care for Massive Esophagogastric Variceal Bleeding in Decompensated Cirrhosis: A Midlife Case Study |
|
11.30-11:55 |
Dr. Himanshu Arora |
The Applications of Machine Learning in Urologic Malignancies |
|
11:30-14:00 |
BREAK |
Session 3. Diagnostics in Personalized Medicine
Date: 30 October 2025 (Thursday)
Time: 14:00 (CET) | 09:00 (EDT) | 21:00 (CST)
|
CET |
Speaker |
Title |
|
14:00–14:10 |
Prof. Dr. Kenneth Pritzker |
Welcome from the session chair |
|
14:10-14:45 |
Prof. Dr. Kenneth Pritzker |
History of Personalized Medicine |
|
14:45-15:20 |
Prof. Dr. Weikuan Gu |
Exploring the capability of ChatGPT 4.0 in generating innovative research hypotheses to address key challenges in the early diagnosis of colorectal cancer (CRC) |
|
15:20-15:35 |
Daniele Bravoco |
Integrating Patient-Derived Organoids and Natural Compounds for Diagnostic and Therapeutic Innovation in IBD |
|
15:35-15:50 |
Ekaterina Sorokina |
Gut Microbiota and Systemic Inflammation in Post-COVID-19 Patients |
|
15:50-16:05 |
Giuseppe D'Albis |
|
|
16:05-16:20 |
Anna Maria Anastasiou |
A Novel TAZ2 Domain Variant in CREBBP Underlines the Need for Personalized Approaches in Menke-Hennekam Syndrome |
|
16:20-16:35 |
Yongting Luo |
Mitochondrial DNA mutations as a candidate risk factor and diagnostic indicator in Marfan Syndrome |
Session 5. Pharmacogenetics, Omics, and Informatics
Date: 31 October 2025 (Friday)
Time: 9:00 (CET) | 03:00 (EST) | 15:00 (CST Asia)
|
CET |
Speaker |
Title |
|
9:00– |
Prof. Enrico Mini |
Welcome from the Session Chair |
|
9:10– |
Dr. Nicola Normanno Invited Speaker |
Cancer Somatic Pharmacogenomics |
|
9:35- |
Prof. Stefania Nobili |
Methodologies and Applications in Pharmacogenetics for Precision Medicine |
|
10:00-10:25 |
Dr. Erika Cecchin |
Germline pharmacogenetics as a tool to prevent cancer drug adverse reactions |
|
10:25-10:50 |
Prof. George P. Patrinos |
Precision Psychiatry |
|
10:50-11:25 |
Prof. Dr. Yves. A. Lussier |
Case-Control No More? How N-of-1 Omics Redefines Therapeutic Evidence |
|
11:25-14:00 |
BREAK |
Session 6. Precision Oncology
Date: 31 October 2025 (Friday)
Time: 14:00 (CET) | 09:00 (EDT) | 21:00 (CST)
|
CEST |
Speaker |
Title |
|
14:00–14:10 |
Dr. Masakazu Kamata |
Welcome from the Session Chair |
|
14:10-14:45 |
Dr. Masakazu Kamata |
Exploring breast cancer brain metastasis and intervention strategies. |
|
14:45-15:10 |
Dr. Jun Ishihara |
Tumour-collagen targeted immunotherapy reduces the side effects and improves the efficacy through precise drug delivery |
| 15:10-15:25 | Pellegrino Mazzone Selected Oral Speaker |
A novel molecular mechanism regulates gastric cancer cell homeostasis |
|
15:25-15:40 |
Fanlin Gu |
Polydopamine-Modified Engineered E. coli for Synergistic Cancer Therapy via Glucose Oxidase-Mediated Starvation and Prodrug Delivery |
|
15:40-15:55 |
Riad BenGhida |
Liquid Biopsy Implementation for NSCLC: What Can New Brunswick Learn from Ontario’s Experience |
|
15:55-16:10 |
Aditya Vayalapalli |
Pathway Analysis of Chemoresistance in Glioblastoma Multiforme |